D
S. Baghery et al.
Letter
Synlett
(14) Rival, Y.; Grassy, G.; Michel, G. Chem. Pharm. Bull. 1992, 40,
1170.
(15) Fisher, M. H.; Lusi, A. J. Med. Chem. 1972, 15, 982.
(16) Rival, Y.; Grassy, G.; Taudou, A.; Ecalle, R. Eur. J. Med. Chem.
1991, 26, 13.
(17) Hamdouchi, C.; de Blas, J.; del Prado, M.; Gruber, J.; Heinz, B. A.;
Vance, L. J. Med. Chem. 1999, 42, 50.
(18) Kaminsky, J. J.; Doweyko, A. M. J. Med. Chem. 1999, 40, 427.
(19) Rupert, K. C.; Henry, J. R.; Dodd, J. H.; Wadsworth, S. A.;
Cavender, D. E.; Olini, G. C.; Fahmy, B.; Siekierka, J. J. Bioorg.
Med. Chem. Lett. 2003, 13, 347.
(i) Lei, S.; Mai, Y.; Yan, C.; Mao, J.; Cao, H. Org. Lett. 2016, 18,
3582. (j) Cao, H.; Zhan, H.; Lin, Y.; Lin, X.; Du, Z.; Jiang, H. Org.
Lett. 2012, 14, 1688. (k) Cao, H.; Liu, X.; Zhao, L.; Cen, J.; Lin, J.;
Zhu, O.; Fu, M. Org. Lett. 2014, 16, 146. (l) Lei, S.; Cao, H.; Chen,
L.; Liu, J.; Cai, H.; Tan, J. Adv. Synth. Catal. 2015, 357, 3109.
(31) (a) Zolfigol, M. A.; Afsharnadery, F.; Baghery, S.; Salehzadeh, S.;
Maleki, F. RSC Adv. 2015, 5, 75555. (b) Zolfigol, M. A.; Safaiee,
M.; Afsharnadery, F.; Bahrami-Nejad, N.; Baghery, S.;
Salehzadeh, S.; Maleki, F. RSC Adv. 2015, 5, 100546. (c) Zolfigol,
M. A.; Kiafar, M.; Yarie, M.; Taherpour, A.; Saeidi-Rad, M. RSC
Adv. 2016, 6, 50100. (d) Zolfigol, M. A.; Khazaei, A.; Alaie, S.;
Baghery, S.; Maleki, F.; Bayat, Y.; Asghari, A. RSC Adv. 2016, 6,
58667.
(20) Hammad, M.; Mequid, A.; Ananni, M. E.; Shafik, N. Egypt. J.
Chem. 1987, 29, 5401.
(21) Badaway, E.; Kappe, T. Eur. J. Med. Chem. 1995, 30, 327.
(22) Hranjec, M.; Kralj, M.; Piantanida, I.; Sedić, M.; Šuman, L.;
Pavelić, K.; Karminski-Zamola, G. J. Med. Chem. 2007, 50, 5696.
(23) Kotovskaya, S. K.; Baskakova, Z. M.; Charushin, V. N.; Chupakhin,
O. N.; Belanov, E. F.; Bormotov, N. I.; Balakhnin, S. M.; Serova, O.
A. Pharm. Chem. J. 2005, 39, 574.
(24) Lhassani, M.; Chavignon, O.; Chezal, J.-M.; Teulade, J.-C.; Chapat,
J.-P.; Snoeck, R.; Andrei, G.; Balzarini, J.; De Clerc, E.; Gueiffier,
A. Eur. J. Med. Chem. 1999, 34, 271.
(25) Guchhait, S. K.; Chaudhary, V.; Madaan, C. Org. Biomol. Chem.
2012, 10, 9271.
(26) Adib, M.; Sheibani, S.; Zhu, L.-G.; Mirzaei, P. Tetrahedron Lett.
2008, 49, 5108.
(27) Adib, M.; Sheibani, S.; Bijanzadeh, H. R.; Zhu, L.-G. Tetrahedron
2008, 64, 10681.
(28) Abdollahi-Alibeik, M.; Rezaeipoor-Anari, A. Catal. Sci. Technol.
2014, 4, 1151.
(29) Venkatesham, R.; Manjula, A.; Vittal Rao, B. J. Heterocycl. Chem.
2011, 48, 942.
(30) (a) Ohta, V. M.; Masaki, M. Bull. Chem. Soc. Jpn. 1960, 33, 1392.
(b) Mohan, D. C.; Rao, S. N.; Adimurthy, S. J. Org. Chem. 2013, 78,
1266. (c) Bagdi, A. K.; Santra, S.; Monir, K.; Hajra, A. Chem.
Commun. 2015, 51, 1555. (d) Liu, P.; Fang, L.-s.; Lei, X.; Lin, G.-q.
Tetrahedron Lett. 2010, 51, 4605. (e) Pericherla, K.; Kaswan, P.;
Pandey, K.; Kumar, A. Synthesis 2015, 47, 887. (f) Zhu, D.-J.; Liu,
M.-C.; Ding, J.-C.; Wu, H.-Y. J. Braz. Chem. Soc. 2009, 20, 482.
(g) Lei, S.; Chen, G. J.; Mai, Y.; Chen, L.; Cai, H.; Tan, J.; Cao, H.
Adv. Synth. Catal. 2016, 358, 67. (h) Wang, C.; Lei, S.; Cao, H.;
Qiu, S.; Liu, J.; Deng, H.; Yan, C. J. Org. Chem. 2015, 80, 12725.
(32) Triphenylammonium Tricyanomethanide (Ph3NH)[C(CN)3]
Ph3N (3 mmol, 0.736 g) was added to a solution of HC(CN)3 (3
mmol, 0.273 g) in H2O (5 mL), and the mixture was stirred for 3
h at 50 °C. The solvent was then evaporated under reduced
pressure and the resulting white powder was dried under
reduced pressure at 100 °C for 3 h. The white solid was washed
with Et2O to remove any unreacted starting materials and then
dried under vacuum to give a white solid; yield: 0.979 g (97%);
mp >350 °C. IR (KBr): 3377, 3037, 2987, 2228, 2110, 1639, 1474,
1389, 1062, 887 cm–1. 1H NMR (400 MHz, DMSO-d6): δ = 6.99 (d,
J = 8.4 Hz, 6 H, ArH), 7.04 (t, J = 7.4 Hz, 3 H, ArH), 7.31 (t, J = 8.0
Hz, 6 H, ArH), 8.55 (s, 1 H, NH). 13C NMR (100 MHz, DMSO-d6):
δ = 41.9, 123.3, 124.1, 129.9, 166.4, 166.6. MS: m/z = 336.3 [M+].
For full analytical data, see the Supporting Information.
N-benzylidene-2-arylimidazo[1,2-a]pyridin-3-amines 4; General
Procedure
(Ph3NH)[C(CN)3] (1 mol%; 0.0034 g) was added to and mixed
with aldehyde 1 (2 mmol), TMSCN (2; 2 mmol; 0.099 g), and
pyridin-2-amine (3; 1 mmol; 0.094 g), and the mixture was
heated at 50 °C for the appropriate time (Table 3). When the
reaction was complete [TLC, hexane–EtOAc (5:2)], the mixture
was washed with H2O (10 mL) and filtered to separate the cata-
lyst from the other materials. (The reaction mixture was insolu-
ble in H2O, and the catalyst was soluble in H2O.) The crude
product was purified by crystallization from EtOH–H2O (10:1).
All products were identified by comparison of their physical
data with those reported in the literature; for spectroscopic
data, see the Supporting Information.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2017, 28, A–D